| AI Risk Prediction for Breast Cancer |
Anne Martel |
Sunnybrook Research Institute |
PLCO |
Nov 13, 2025 |
PLCOI-1924 |
| Predictive analytics with automated machine learning applied to ovarian cancer image data |
Jacob Levman |
St. Francis Xavier University |
PLCO |
Nov 13, 2025 |
PLCOI-1992 |
| Replication and Comparative Evaluation of Deep Learning Models (Sybil and M3FM) for Lung Cancer Risk Prediction Using NLST Low-Dose CT Scans |
Aristotelis Tsirigos |
NYU Langone Health |
NLST |
Nov 13, 2025 |
NLST-1481 |
| Development and Validation of Cancer Risk Prediction Models Using Publicly Available Cohort Data |
Luke Stetson |
PreOncology |
NLST |
Nov 13, 2025 |
NLST-1477 |
| Automated Data Harmonization |
Mohammed Eslami |
Netrias, LLC |
IDATA |
Oct 22, 2025 |
IDATA-92 |
| Investigating Thymic Function in Human Papillomavirus (HPV)-Related Cancer Risk and Survival |
Eric Engels |
National Cancer Institute, National Institutes of Health |
PLCO |
Sep 29, 2025 |
PLCO-1991 |
| Comparison of Recurrent Neural Network (RNN) versus Survival Analysis for Lung Cancer Risk Prediction |
Li Cheung |
National Cancer Institute |
NLST |
Sep 29, 2025 |
NLST-1478 |
| Enhancing lesion segmentation algorithm to include lung nodules |
Maria Wimmer |
VRVis GmbH |
NLST |
Sep 24, 2025 |
NLST-1465 |
| Irish MOdelling of Diagnosis-related And Lead-time Overdiagnosis in Lung Cancer Screening (I-MODAL-Lung) |
Patrick Redmond |
Royal College of Surgeons in Ireland |
NLST |
Sep 24, 2025 |
NLST-1442 |
| Predictive analytics with machine learning for ovarian cancer |
Jacob Levman |
St. Francis Xavier University |
PLCO |
Sep 22, 2025 |
PLCO-1990 |
| AI-Driven Analyses of Morphological and Phenotypic Profiles Across Cancers |
JUNHAN ZHAO |
The University of Chicago |
PLCO |
Sep 22, 2025 |
PLCOI-1985 |
| Genetic Associations Between High-Risk Pulmonary Nodules and Risk of Lung Adenocarcinoma and Squamous Cell Carcinoma |
Douglas Easton |
University of Cambridge |
PLCO |
Sep 22, 2025 |
PLCO-1987 |
| Development and Validation of Cancer Risk Prediction Models Using Publicly Available Cohort Data |
Luke Stetson |
PreOncology |
PLCO |
Sep 22, 2025 |
PLCO-1986 |
| Geographical and socioeconomic disparities across site-specific and pan-cancer risk factors |
Mikko Myrskylä |
Max Planck Institute for Demographic Research |
PLCO |
Sep 22, 2025 |
PLCO-1983 |
| Developing AI-Driven Personalized Early Detection and Clinical Decision Support for Prostate Cancer |
Ken Chen |
University of Texas MD Anderson Cancer Center |
PLCO |
Sep 22, 2025 |
PLCO-1969 |
| Metabolomic profiles of body composition measures |
Erikka Loftfield |
National Cancer Institute |
IDATA |
Sep 15, 2025 |
IDATA-94 |
| Early-Stage Inference on Cancer Survival Rates in the NLST Trial |
Jeffrey T. Leek |
Fred Hutchinson Cancer Center |
NLST |
Sep 9, 2025 |
NLST-1468 |
| Enhancing colorectal cancer risk prediction through AI-augmented variable section and stratification |
Min Zhang |
University of California, Irvine |
PLCO |
Sep 9, 2025 |
PLCO-1982 |
| Breast Cancer Metabolomics |
Steven Moore |
National Cancer Institute |
PLCO |
Sep 9, 2025 |
PLCO-1981 |
| Integrating PFAS Exposure, Metabolomics, and Genetics to Address Colorectal Cancer Risk |
Tanya Alderete |
Johns Hopkins University |
PLCO |
Sep 9, 2025 |
PLCO-1977 |
